Merck & Co., Inc. Earnings Per Share (Diluted)
Merck & Co., Inc. (MRK) reported Earnings Per Share (Diluted) of -$0.54 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-07
- Merck & Co., Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.54, a 130.68% decline year-over-year.
- Merck & Co., Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.72, a 185.57% decline year-over-year.
- Merck & Co., Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $1.19, a 19.28% decline year-over-year.
- Merck & Co., Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $2.32, a 87.10% increase year-over-year.
- Merck & Co., Inc. earnings per share, diluted for fiscal 2025 was $7.28, a 8.01% increase from fiscal 2024.
- Merck & Co., Inc. earnings per share, diluted for fiscal 2024 was $6.74, a 4714.29% increase from fiscal 2023.
- Merck & Co., Inc. earnings per share, diluted for fiscal 2023 was $0.14, a 97.55% decline from fiscal 2022.
- Merck & Co., Inc. earnings per share, diluted for fiscal 2022 was $5.71, a 11.09% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.54 10-Q · filed 2026-08-07 | -$2.26 10-Q · filed 2026-08-07 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-08-07 | $1.28 derived: net income ÷ weighted average shares · filed 2026-08-07 | |||
| 2026-03-31 | -$1.72 10-Q · filed 2026-05-04 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-05-04 | $1.81 derived: net income ÷ weighted average shares · filed 2026-05-04 | $3.59 derived: net income ÷ weighted average shares · filed 2026-08-07 | |||
| 2025-12-31 | $1.19 derived: net income ÷ weighted average shares · filed 2026-02-24 | $3.51 derived: net income ÷ weighted average shares · filed 2026-02-24 | $5.27 derived: net income ÷ weighted average shares · filed 2026-08-07 | $7.28 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $2.32 10-Q · filed 2025-11-05 | $4.08 derived: net income ÷ weighted average shares · filed 2026-08-07 | $6.08 10-Q · filed 2025-11-05 | $7.56 derived: net income ÷ weighted average shares · filed 2026-08-07 | |||
| 2025-06-30 | $1.76 10-Q · filed 2026-08-07 | $3.77 10-Q · filed 2026-08-07 | $5.24 derived: net income ÷ weighted average shares · filed 2026-08-07 | $6.48 derived: net income ÷ weighted average shares · filed 2026-08-07 | |||
| 2025-03-31 | $2.01 10-Q · filed 2026-05-04 | $3.48 derived: net income ÷ weighted average shares · filed 2026-05-04 | $4.72 derived: net income ÷ weighted average shares · filed 2026-05-04 | $6.87 derived: net income ÷ weighted average shares · filed 2026-05-04 | |||
| 2024-12-31 | $1.48 derived: net income ÷ weighted average shares · filed 2026-02-24 | $2.72 derived: net income ÷ weighted average shares · filed 2026-02-24 | $4.86 derived: net income ÷ weighted average shares · filed 2026-02-24 | $6.74 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $1.24 10-Q · filed 2025-11-05 | $3.39 derived: net income ÷ weighted average shares · filed 2025-11-05 | $5.26 10-Q · filed 2025-11-05 | $4.78 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2024-06-30 | $2.14 10-Q · filed 2025-08-05 | $4.02 10-Q · filed 2025-08-05 | $3.54 derived: net income ÷ weighted average shares · filed 2026-02-24 | $5.40 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2024-03-31 | $1.87 10-Q · filed 2025-05-02 | $1.39 derived: net income ÷ weighted average shares · filed 2026-02-24 | $3.26 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.91 derived: net income ÷ weighted average shares · filed 2026-02-24 | |||
| 2023-12-31 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-02-24 | $1.38 derived: net income ÷ weighted average shares · filed 2026-02-24 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-02-24 | $0.14 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $1.86 10-Q · filed 2024-11-06 | -$0.48 derived: net income ÷ weighted average shares · filed 2024-11-06 | $0.62 10-Q · filed 2024-11-06 | $1.81 derived: net income ÷ weighted average shares · filed 2025-02-25 | |||
| 2023-06-30 | -$2.35 10-Q · filed 2024-08-05 | -$1.24 10-Q · filed 2024-08-05 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-02-25 | $1.22 derived: net income ÷ weighted average shares · filed 2025-02-25 | |||
| 2023-03-31 | $1.11 10-Q · filed 2024-05-03 | $2.29 derived: net income ÷ weighted average shares · filed 2025-02-25 | $3.57 derived: net income ÷ weighted average shares · filed 2025-02-25 | $5.12 derived: net income ÷ weighted average shares · filed 2025-02-25 | |||
| 2022-12-31 | $1.18 derived: net income ÷ weighted average shares · filed 2025-02-25 | $2.46 derived: net income ÷ weighted average shares · filed 2025-02-25 | $4.01 derived: net income ÷ weighted average shares · filed 2025-02-25 | $5.71 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $1.28 10-Q · filed 2023-11-03 | $2.83 derived: net income ÷ weighted average shares · filed 2023-11-03 | $4.53 10-Q · filed 2023-11-03 | $6.01 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2022-06-30 | $1.55 10-Q · filed 2023-08-07 | $3.25 10-Q · filed 2023-08-07 | $4.73 derived: net income ÷ weighted average shares · filed 2024-02-26 | $6.53 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2022-03-31 | $1.70 10-Q · filed 2023-05-05 | $3.18 derived: net income ÷ weighted average shares · filed 2024-02-26 | $4.98 derived: net income ÷ weighted average shares · filed 2024-02-26 | $5.59 derived: net income ÷ weighted average shares · filed 2024-02-26 | |||
| 2021-12-31 | $1.48 derived: net income ÷ weighted average shares · filed 2024-02-26 | $3.28 derived: net income ÷ weighted average shares · filed 2024-02-26 | $3.89 derived: net income ÷ weighted average shares · filed 2024-02-26 | $5.14 10-K · filed 2024-02-26 | |||
| 2021-09-30 | $1.80 10-Q · filed 2022-11-03 | $2.41 derived: net income ÷ weighted average shares · filed 2022-11-03 | $3.66 10-Q · filed 2022-11-03 | $2.83 derived: net income ÷ weighted average shares · filed 2023-02-24 | |||
| 2021-06-30 | $0.61 10-Q · filed 2022-08-05 | $1.86 10-Q · filed 2022-08-05 | $1.04 derived: net income ÷ weighted average shares · filed 2023-02-24 | $2.19 derived: net income ÷ weighted average shares · filed 2023-02-24 | |||
| 2021-03-31 | $1.25 10-Q · filed 2022-05-05 | $0.43 derived: net income ÷ weighted average shares · filed 2023-02-24 | $1.59 derived: net income ÷ weighted average shares · filed 2023-02-24 | ||||
| 2020-12-31 | -$0.82 derived: net income ÷ weighted average shares · filed 2023-02-24 | $0.33 derived: net income ÷ weighted average shares · filed 2023-02-24 | $2.78 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $1.16 10-Q · filed 2021-11-05 | $3.61 10-Q · filed 2021-11-05 | |||||
| 2020-06-30 | $1.18 10-Q · filed 2021-08-09 | $2.45 10-Q · filed 2021-08-09 | |||||
| 2020-03-31 | $1.26 10-Q · filed 2021-05-05 | ||||||
| 2019-12-31 | $3.81 10-K · filed 2022-02-25 | ||||||
| 2019-09-30 | $0.74 10-Q · filed 2020-11-05 | $2.89 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $1.03 10-Q · filed 2020-08-05 | $2.15 10-Q · filed 2020-08-05 | |||||
| 2019-03-31 | $1.12 10-Q · filed 2020-05-06 | ||||||
| 2018-12-31 | $2.32 10-K · filed 2021-02-25 | ||||||
| 2018-09-30 | $0.73 10-Q · filed 2019-11-05 | $1.63 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $0.63 10-Q · filed 2019-08-06 | $0.90 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $0.27 10-Q · filed 2019-05-08 | ||||||
| 2017-12-31 | $0.87 10-K · filed 2020-02-26 | ||||||
| 2017-09-30 | -$0.02 10-Q · filed 2018-11-06 | $1.25 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | $0.71 10-Q · filed 2018-08-07 | $1.27 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | $0.56 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | $1.41 10-K · filed 2019-02-27 | ||||||
| 2016-09-30 | $0.78 10-Q · filed 2017-11-07 | $1.62 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | $0.43 10-Q · filed 2017-08-08 | $0.83 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | $0.40 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | $1.56 10-K · filed 2018-02-27 | ||||||
| 2015-09-30 | $0.64 10-Q · filed 2016-11-07 | $1.22 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | $0.24 10-Q · filed 2016-08-08 | $0.57 10-Q · filed 2016-08-08 | |||||
| 2015-03-31 | $0.33 10-Q · filed 2016-05-09 | ||||||
| 2014-12-31 | $4.07 10-K · filed 2017-02-28 | ||||||
| 2014-09-30 | $0.31 10-Q · filed 2015-11-05 | $1.57 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | $0.68 10-Q · filed 2015-08-06 | $1.25 10-Q · filed 2015-08-06 | |||||
| 2014-03-31 | $0.57 10-Q · filed 2015-05-07 | ||||||
| 2013-12-31 | $0.26 derived: net income ÷ weighted average shares · filed 2016-02-26 | $0.64 derived: net income ÷ weighted average shares · filed 2016-02-26 | $0.94 derived: net income ÷ weighted average shares · filed 2016-02-26 | $1.47 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $0.38 10-Q · filed 2014-11-10 | $0.68 derived: net income ÷ weighted average shares · filed 2014-11-10 | $1.20 10-Q · filed 2014-11-10 | $1.50 derived: net income ÷ weighted average shares · filed 2015-02-27 | |||
| 2013-06-30 | $0.30 10-Q · filed 2014-08-07 | $0.82 10-Q · filed 2014-08-07 | $1.12 derived: net income ÷ weighted average shares · filed 2015-02-27 | $1.68 derived: net income ÷ weighted average shares · filed 2015-02-27 | |||
| 2013-03-31 | $0.52 10-Q · filed 2014-05-08 | $0.82 derived: net income ÷ weighted average shares · filed 2015-02-27 | $1.38 derived: net income ÷ weighted average shares · filed 2015-02-27 | $1.96 derived: net income ÷ weighted average shares · filed 2015-02-27 | |||
| 2012-12-31 | $0.30 derived: net income ÷ weighted average shares · filed 2015-02-27 | $0.86 derived: net income ÷ weighted average shares · filed 2015-02-27 | $1.44 derived: net income ÷ weighted average shares · filed 2015-02-27 | $2.00 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $0.56 10-Q · filed 2013-11-07 | $1.14 derived: net income ÷ weighted average shares · filed 2013-11-07 | $1.71 10-Q · filed 2013-11-07 | $2.20 derived: net income ÷ weighted average shares · filed 2014-02-27 | |||
| 2012-06-30 | $0.58 10-Q · filed 2013-08-07 | $1.15 10-Q · filed 2013-08-07 | $1.64 derived: net income ÷ weighted average shares · filed 2014-02-27 | $2.19 derived: net income ÷ weighted average shares · filed 2014-02-27 | |||
| 2012-03-31 | $0.56 10-Q · filed 2013-05-09 | $1.06 derived: net income ÷ weighted average shares · filed 2014-02-27 | $1.60 derived: net income ÷ weighted average shares · filed 2014-02-27 | $2.25 derived: net income ÷ weighted average shares · filed 2014-02-27 | |||
| 2011-12-31 | $0.49 derived: net income ÷ weighted average shares · filed 2014-02-27 | $1.04 derived: net income ÷ weighted average shares · filed 2014-02-27 | $1.69 derived: net income ÷ weighted average shares · filed 2014-02-27 | $2.02 10-K · filed 2014-02-27 | |||
| 2011-09-30 | $0.55 10-Q · filed 2012-11-09 | $1.20 derived: net income ÷ weighted average shares · filed 2012-11-09 | $1.53 10-Q · filed 2012-11-09 | -$263.86 derived: net income ÷ weighted average shares · filed 2013-02-28 | |||
| 2011-06-30 | $0.65 10-Q · filed 2012-08-07 | $0.98 10-Q · filed 2012-08-07 | -$2.41 derived: net income ÷ weighted average shares · filed 2013-02-28 | -$216.81 derived: net income ÷ weighted average shares · filed 2013-02-28 | |||
| 2011-03-31 | $0.34 10-Q · filed 2012-05-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2013-02-28 | -$0.81 derived: net income ÷ weighted average shares · filed 2013-02-28 | -$168.58 derived: net income ÷ weighted average shares · filed 2013-02-28 | |||
| 2010-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2013-02-28 | $0.06 derived: net income ÷ weighted average shares · filed 2013-02-28 | -$0.54 derived: net income ÷ weighted average shares · filed 2013-02-28 | $0.28 10-K · filed 2013-02-28 | |||
| 2010-09-30 | $0.11 10-Q · filed 2011-11-08 | $0.35 derived: net income ÷ weighted average shares · filed 2011-11-08 | $0.44 10-Q · filed 2011-11-08 | $2.59 derived: net income ÷ weighted average shares · filed 2012-02-28 | |||
| 2010-06-30 | $0.24 10-Q · filed 2011-08-08 | $0.33 10-Q · filed 2011-08-08 | $2.50 derived: net income ÷ weighted average shares · filed 2012-02-28 | $3.92 derived: net income ÷ weighted average shares · filed 2012-02-28 | |||
| 2010-03-31 | $0.09 10-Q · filed 2011-05-09 | $2.29 derived: net income ÷ weighted average shares · filed 2012-02-28 | $3.81 derived: net income ÷ weighted average shares · filed 2012-02-28 | $4.63 derived: net income ÷ weighted average shares · filed 2012-02-28 | |||
| 2009-12-31 | $2.34 derived: net income ÷ weighted average shares · filed 2012-02-28 | $4.05 derived: net income ÷ weighted average shares · filed 2012-02-28 | $4.91 derived: net income ÷ weighted average shares · filed 2012-02-28 | $5.65 10-K · filed 2012-02-28 | |||
| 2009-09-30 | $1.61 10-Q · filed 2010-11-08 | $0.29 10-Q · filed 2009-10-29 | $2.35 derived: net income ÷ weighted average shares · filed 2010-11-08 | $3.03 10-Q · filed 2010-11-08 | $1.13 10-Q · filed 2009-10-29 | ||
| 2009-06-30 | $0.74 10-Q · filed 2010-08-06 | $0.38 10-Q · filed 2009-07-24 | $1.41 10-Q · filed 2010-08-06 | $0.85 10-Q · filed 2009-07-24 | |||
| 2009-03-31 | $0.67 10-Q · filed 2010-05-07 | ||||||
| 2008-12-31 | $3.63 10-K · filed 2011-02-28 | ||||||
| 2008-09-30 | $0.35 10-Q · filed 2009-10-29 | $0.78 10-Q · filed 2009-10-29 | |||||
| 2008-06-30 | $0.26 10-Q · filed 2009-07-24 | $0.43 10-Q · filed 2009-07-24 | |||||
| 2007-12-31 | $1.49 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |